Evidence emerging from literature and clinical trials suggests that dietary-derived polyphenols could represent a helpful supplement in COVID-19 therapy, by contrasting viral load, suppressing inflammation, promoting ACE2/Ang- (1–7)/MasR axis, protecting organs from damage, preventing complications and reducing illness severity (295). This evidence concerns the gene MAS1L and COVID-19.